Anti-S100A4抗体(ab58597)
Key features and details
- Goat polyclonal to S100A4
- Suitable for: IHC-P, WB
- Reacts with: Human
- Isotype: IgG
选择批间可重复性更高的重组抗体
- 研究可靠 —— 各批次间结果一致且可重复
- 长期批量供应 —— 采用重组技术，可实现快速生产
- 首次实验即可成功 —— 经过大量验证确认了特异性
- 符合伦理标准 —— 产品不含动物成分
概述
-
产品名称
Anti-S100A4抗体
参阅全部 S100A4 一抗 -
描述
山羊多克隆抗体to S100A4 -
宿主
Goat -
特异性
Both variants (NP_002952.1; NP_062427.1) represent identical protein. -
经测试应用
适用于: IHC-P, WBmore details -
种属反应性
与反应: Human
预测可用于: Mouse, Rat, Dog
-
免疫原
Synthetic peptide:
CNEFFEGFPDKQP
, corresponding to C terminal amino acids 86-98 of Human S100A4 -
阳性对照
- Human Placenta lysate.
-
常规说明
The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.
If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As
性能
-
形式
Liquid -
存放说明
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles. -
存储溶液
pH: 7.30
Preservative: 0.02% Sodium azide
Constituents: 0.5% Tris buffered saline, 0.5% BSA -
Concentration information loading... -
纯度
Immunogen affinity purified -
纯化说明
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide. -
克隆
多克隆 -
同种型
IgG -
研究领域
相关产品
-
Compatible Secondaries
-
Isotype control
应用
The Abpromise guarantee
Abpromise™承诺保证使用ab58597于以下的经测试应用
“应用说明”部分 下显示的仅为推荐的起始稀释度；实际最佳的稀释度/浓度应由使用者检定。
| 应用 | Ab评论 | 说明 |
|---|---|---|
| IHC-P |
Use at an assay dependent concentration.
|
|
| WB |
Use a concentration of 0.03 - 0.1 µg/ml. Detects a band of approximately 13 kDa (predicted molecular weight: 12 kDa).
1 hour primary incubation is recommended for this product. |
| 说明 |
|---|
|
IHC-P
Use at an assay dependent concentration. |
|
WB
Use a concentration of 0.03 - 0.1 µg/ml. Detects a band of approximately 13 kDa (predicted molecular weight: 12 kDa). 1 hour primary incubation is recommended for this product. |
靶标
-
组织特异性
Ubiquitously expressed. -
序列相似性
Belongs to the S-100 family.
Contains 2 EF-hand domains. - Information by UniProt
-
数据库链接
- Entrez Gene: 403787 Dog
- Entrez Gene: 6275 Human
- Entrez Gene: 20198 Mouse
- Entrez Gene: 24615 Rat
- Omim: 114210 Human
- SwissProt: Q9TV56 Dog
- SwissProt: P26447 Human
- SwissProt: P07091 Mouse
see all -
别名
- 18A2 antibody
- 42A antibody
- calcium Placental protein antibody
see all
图片
-
Western blot - Anti-S100A4 antibody (ab58597)Anti-S100A4 antibody (ab58597) at 0.03 µg/ml + Peripheral blood mononuclear cell lysate (in RIPA buffer) at 35 µg
Predicted band size: 12 kDa
Observed band size: 13 kDa why is the actual band size different from the predicted?
Primary incubation was 1 hour. Detected by chemiluminescence. -
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-S100A4 antibody (ab58597)ab58597 at a concentration of 2µg/ml staining S100A4 in Human small intestine tissue sections by immunohistochemistry (paraffin-embedded). Steamed antigen retrieval with citrate buffer pH 6, HRP-staining.
数据表及文件
-
Datasheet download
文献 (5)
ab58597 被引用在 5 文献中.
- Kalgudde Gopal S et al. Wound infiltrating adipocytes are not myofibroblasts. Nat Commun 14:3020 (2023). PubMed: 37230982
- Xiong Y et al. Rutaecarpine prevents the malignant biological properties of breast cancer cells by the miR-149-3p/S100A4 axis. Ann Transl Med 10:930 (2022). PubMed: 36172090
- Jiang D et al. Injury triggers fascia fibroblast collective cell migration to drive scar formation through N-cadherin. Nat Commun 11:5653 (2020). PubMed: 33159076
- Lerbs T et al. CD47 prevents the elimination of diseased fibroblasts in scleroderma. JCI Insight 5:N/A (2020). PubMed: 32814713
- Rasanen K et al. Comparative secretome analysis of epithelial and mesenchymal subpopulations of head and neck squamous cell carcinoma identifies S100A4 as a potential therapeutic target. Mol Cell Proteomics 12:3778-92 (2013). PubMed: 24037664
